Skip to main content

Table 2 Mean availability of individual SRHC across sectors, by country

From: Access to sexual and reproductive health commodities in East and Southern Africa: a cross-country comparison of availability, affordability and stock-outs in Kenya, Tanzania, Uganda and Zambia

Commodities Mean Availability (%)
Kenya Tanzania Uganda Zambia
Public Private PNFP Public Private PNFP Public Private PNFP Public Private PNFP
Family Planning
 Oral contraceptivea 91 80 72 69 47 40 75 36 43 91 67 83
 Levonorgestrel 750 mcg 47 71 32 8 0 0 35 30 24 41 61 41
 Injectable contraceptiveb 92 32 66 82 59 53 62 51 67 72 30 79
 Male condoms 84 85 79 82 52 47 93 72 81 89 89 86
 Female condoms 56 13 39 33 22 27 18 17 33 60 5 48
 Intrauterine contraceptive devicen 82 29 48 62 65 53 72 39 56 51 2 41
 Implantc,n 87 30 79 84 78 73 89 64 67 71 0 62
 Diaphragm 0 0 4 0 0 0 0 0 0 0 0 0
Maternal Health
 Oxytocin injectionn,p 87 41 67 75 42 56 80 50 64 94 50 78
 Misoprostol 33 34 35 49 35 22 82 48 56 11 27 26
 Methyldopak,m,n 77 77 83 76 73 73 24 14 36 12 51 17
 Magnesium sulphated,n,p 59 10 44 70 18 48 69 10 42 13 0 12
 Calcium gluconatek,m,n,q 71 29 71 44 0 44 43 8 27 67 0 0
 Ferrous salt 57 50 43 5 3 4 4 27 37 75 55 71
 Folic acid 55 77 79 63 50 48 64 71 63 80 82 79
 Ferrous Salt: Folic Acid Tabletg 62 8 48 20 5 14 27 10 33 1 7 2
Antibiotics and Antifungals
 Metronidazole 68 80 87 61 92 86 75 94 84 88 87 93
 Clotrimazolee 70 74 83 39 47 38 67 63 67 24 45 17
 Gentamicinn 58 39 61 43 45 40 30 67 67 48 33 50
 Procaine benzylpenicillin NS NS NS 26 33 36 33 48 44 2 34 7
 Benzathine benzylpenicillinn 39 16 30 80 60 70 70 72 67 60 69 74
 Benzylpenicillin 46 34 50 NS NS NS NS NS NS 82 34 86
 Amoxicillinf 62 38 43 74 30 42 40 40 49 77 88 81
Newborn- and Child Health
 Dexamethasonek,o,q 81 82 63 10 27 32 76 50 46 67 50 0
 Zinc ORS co-pack 68 28 41 29 3 4 44 6 26 13 5 17
 Zinch 86 82 93 36 75 74 44 70 67 53 46 60
 ORS sachetsi 77 73 83 75 72 82 53 70 63 32 57 48
 Chlorhexidine 4% 38 9 30 7 3 6 26 6 19 6 3 10
SRH medical devices
 Vasectomy kitk,l,n 19 6 8 3 5 0 17 8 15 7 4 14
 Tubal ligation kitk,l,n 23 35 13 13 9 5 17 11 24 10 1 10
 Manual vacuum aspiration kitj,n 66 59 56 38 38 26 48 36 48 54 38 64
 Speculumj,o 86 78 84 84 67 66 88 75 92 84 38 94
 Cervical dilatorj,n 34 41 49 12 17 14 46 31 58 28 25 25
 Incubator 68 47 79 11 13 16 16 4 14 27 13 53
 Monitork,n 39 53 63 11 15 16 22 11 33 14 13 17
 Ultrasound scank,o 45 53 63 13 45 36 52 63 92 19 50 22
 Ventilatork,n 32 41 42 5 5 6 9 8 3 9 25 17
 Foetal scopej,n 82 78 88 97 80 92 94 92 91 86 63 78
 Resuscitator (adult size)j,n 45 33 49 31 22 18 33 44 45 28 25 39
 Resuscitator (infant size)j,n 63 44 53 63 38 46 65 56 70 50 38 72
 Bag and mask (size 0)j,o 58 52 77 59 37 46 68 25 62 52 38 75
 Suction devicej 68 67 79 71 52 62 65 54 81 75 50 81
 Training mannequin (infant)j,n 20 15 23 36 22 32 26 6 27 26 0 33
  1. NS not surveyed
  2. a‘Oral contraceptive’ combines availability of ethinylestradiol + levonorgestrel (multiple formulations) and/or ethinylestradiol + norethisterone (multiple formulations) and/or ethinylestradiol + desorgestrel (multiple formulations) and/or levonorgestrel 30mcg at the facility
  3. b‘Injectable contraceptive’ combines availability of medroxyprogesterone acetate (150 mg in 1 ml vial or 104 mg in 1 ml vial) and/or norethisterone enanthate 200 mg/ml in 1 ml vial and/or estradiol cypionate + medroxyprogesterone acetate (5 mg + 25 mg) at the facility
  4. c‘Implant’ combines availability of levonorgestrel implant and/or etonogestrel implant at the facility
  5. d‘Magnesium sulphate’ combines availability of magnesium sulphate 500 mg in 1 ml and/or magnesium sulphate 500 mg in 2 ml and/or magnesium sulphate 500 mg in 10 ml at the facility
  6. e‘Clotrimazole’ combines availability of clotrimazole cream (1%, 15 g tube) and/or clotrimazole pessary (100 mg, 200 mg or 500 mg)
  7. f‘Amoxicillin’ combines availability of amoxicillin 125 mg and/or amoxicillin 250 mg at the facility
  8. g‘Ferrous salt: folic acid tablets’ combines availability of the ferrous salt: folic acid (60 mg + 400mcg) and/or ferrous salt: folic acid (150 mg + 500mcg) and/or ferrous salt: folic acid (200 mg + 500mcg) at the facility
  9. h‘Zinc’ combines availability of zinc 10 mg in 5 ml syrup and/or zinc 20 mg and/or zinc ORS co-pack at the facility
  10. i‘ORS sachets’ combines availability of ORS sachets of 200 ml and/or 500 ml and/or 1 L and/or zinc ORS co-pack at the facility
  11. jAvailable from health centre and up in Kenya
  12. kAvailable from primary/county hospital and up in Kenya
  13. lAvailable from health centre and up in Tanzania
  14. mAvailable from council hospital and up in Tanzania
  15. nAvailable from health centre III and up in Uganda
  16. oAvailable from health centre IV and up in Uganda
  17. pAvailable from general hospital and up in Zambia
  18. qAvailable from central hospital and up in Zambia
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us